Replies to post #6609 on Arbutus Biopharma Corporation (ABUS)

[mick]

Chardan Capital Reaffirms Their Buy Rating on Arbutus Biopharma (ABUS) • TipRanks • 06/28/2022 11:55:13 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 06/27/2022 01:01:27 PM
Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update • GlobeNewswire Inc. • 06/25/2022 08:05:00 AM